Skip to content
Education Use Only
For educational use only — The physician’s written order and the unit protocol always govern
Medical Associates  ·  Department of Nephrology ← Nursing cards  ·  Maintenance Hemodialysis  ·  urinenephrology.org
Dialysis Nursing Reference Card  ·  Maintenance Hemodialysis

N13 — Nutrition at the Chair

Spot wasting early, feed safely, reinforce the diet plan, and get fish oil right.
Andrew Bland, MD, FACP, FAAP Reviewed September 2026 · v1.0 draft Prints on one sheet, front and back
N13 — Nutrition at the Chair FRONT
Front · at the chair

When: every weigh-in, snacks and meal trays, diet questions, and the monthly lab review.

Do this

  1. Weigh accurately before and after every treatment. Repeatedly finishing below target may reflect tissue loss, fluid change, or a measurement/target issue. Report the trend and assess appetite, function, and volume; it is not proof of tissue loss [11].
  2. Ask weekly: appetite? eating on dialysis days? nausea, trouble chewing or swallowing, mouth pain? groceries? Document it for the dietitian [9].
  3. Eating on treatment — stable patients only: a small, protein-focused snack early in the run (timing per your unit protocol), upright and fully awake, away from lines and access [5].
  4. Patients whose BP drops on treatment: eat before arrival or after treatment — not on the machine [4]. See N5: Intradialytic Hypotension: Chair-Side Response.
  5. Reinforce the dietitian’s plan: protein at every meal; less salt to control thirst; avoid foods with “PHOS” in the ingredient list; don’t cut out fruits and vegetables without the dietitian [9].
  6. Fish oil (product per your unit protocol): confirm it is on the medication list and ask how many capsules a day. Dose by the EPA + DHA on the label — about 2.4 g/day is the PISCES dose [6].

Call the nephrologist (and tell the dietitian) when

  • Unintentional weight loss of 5% over 3 months or 10% over 6 months, or the post-weight keeps landing below target [11].
  • Albumin falls below 3.5 g/dL or drops noticeably from the patient’s usual — think infection or inflammation first, intake second [3].
  • Eating poorly for more than 2 weeks, trouble swallowing, or mouth pain; or signs of infection (fever, exit-site redness, old-graft tenderness, foot wounds).
  • nPCR below 0.8 g/kg/day, or phosphorus, potassium, or BUN suddenly “better” — the patient may have stopped eating [10].
  • Symptomatic low BP after eating on the machine [4].
  • On fish oil: black stools, needle-site bleeding that won’t stop, new palpitations or an irregular pulse, or a newly found fish or shellfish allergy [12].

Don’t

  • Don’t treat a low albumin as only a diet problem [3].
  • Don’t feed a patient who is dropping BP, drowsy, or struggling to swallow [4,5].
  • Don’t tell patients to eat less protein to control phosphorus — binders and additive avoidance do that, and low protein intake is associated with death on dialysis [9,10].
  • Don’t remove fruits and vegetables from the diet without the dietitian.
  • Don’t count “fish oil 1,000 mg” as the dose; count EPA plus DHA [6].
  • Don’t expect fish oil to raise albumin; it is for cardiovascular protection [7,8].
N13 — Nutrition at the Chair BACK
Back · why, and the evidence

Why

  1. Protein-energy wasting affects 28% to 54% of dialysis patients across studies [1], and malnutrition raises the risk of death about 1.5-fold on hemodialysis [2].
  2. Albumin tracks inflammation: blocking IL-6 raised albumin 0.21–0.28 g/dL in 12 weeks with no change in food [3].
  3. Eating on the machine is a trade: it caused 13 versus 2 symptomatic low-BP episodes in a small study [4], yet experts support it for patients without contraindications [5].
  4. In PISCES, fish oil cut serious cardiovascular events from 33.7% to 20.8% of patients over about 2 years, with less serious bleeding (4.8% vs 7.6%); survival did not change [6].
  5. Fish oil does not meaningfully raise albumin: 14 pooled trials showed no change (0.00 g/dL) [7], and the only trial sized for albumin found +0.1 versus 0.0 g/dL (P = 0.295) [8].

Go deeper

References

  1. Carrero JJ, et al. Global prevalence of protein-energy wasting in kidney disease: a meta-analysis (ISRNM). J Ren Nutr. 2018;28:380-392. PubMed 30348259
  2. Rashid I, et al. Malnutrition as a potential predictor of mortality in CKD patients on dialysis: a systematic review and meta-analysis. Clin Nutr. 2024;43:1760-1769. PubMed 38852509
  3. Chertow GM, et al. IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nat Med. 2024;30:2328-2336. PubMed 38796655
  4. Sherman RA, et al. Postprandial blood pressure changes during hemodialysis. Am J Kidney Dis. 1988;12:37-39. PubMed 3389352
  5. Kistler BM, et al. Eating during hemodialysis treatment: a consensus statement from the ISRNM. J Ren Nutr. 2018;28:4-12. PubMed 29249295
  6. Lok CE, et al. Fish-oil supplementation and cardiovascular events in patients receiving hemodialysis (PISCES). N Engl J Med. 2026;394:128-137. PubMed 41201837
  7. Liu R, et al. Effects of omega-3 fatty acid intake in patients undergoing dialysis: a systematic review and meta-analysis of RCTs. J Am Nutr Assoc. 2022;41:697-712. PubMed 34635026
  8. Daud ZA, et al. Effects of protein and omega-3 supplementation, provided during regular dialysis sessions, on nutritional and inflammatory indices in hemodialysis patients. Vasc Health Risk Manag. 2012;8:187-195. PubMed 22536073
  9. Ikizler TA, et al. KDOQI clinical practice guideline for nutrition in CKD: 2020 update. Am J Kidney Dis. 2020;76(3 Suppl 1):S1-S107. PubMed 32829751
  10. Shinaberger CS, et al. Longitudinal associations between dietary protein intake and survival in hemodialysis patients. Am J Kidney Dis. 2006;48:37-49. PubMed 16797385
  11. Fouque D, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73:391-398. PubMed 18094682
  12. Gencer B, et al. Effect of long-term marine omega-3 fatty acids supplementation on the risk of atrial fibrillation in randomized cardiovascular outcome trials. Circulation. 2021;144:1981-1990. PubMed 34612056

Reviewed by Andrew Bland, MD, FACP, FAAP · v1.0 draft 2026-09-26. For education; the physician’s written order and the unit protocol always govern.

Visual reference

N13 · Nutrition at the Chair visual summary. Open for the full image and text version.
N13 · Nutrition at the Chair: full graphic and text version

Browse the visual reference library · Download lesson Markdown